SUBJECTS : Bone Oncology | Cancer | Cancer Treatment | Radiotherapy | Surgery | Pharmacolog
Journal of Bone Oncology: 2023, vol: 43, issue:
- 1)- Gwenyth J Joseph, Douglas B Johnson, Rachelle W Johnson. Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms. Journal of bone oncology. 2023, 43: 100505
Cited : 5Read More - 2)- Yiming Zhang, Nan Ru, Zhaowen Xue, Wenyi Gan, Ruilin Pan, Zelin Wu, Zihang Chen, Huajun Wang, Xiaofei Zheng. The role of mitochondria-related lncRNAs in characterizing the immune landscape and supervising the prognosis of osteosarcoma. Journal of bone oncology. 2023, 43: 100506Cited : 2Read More
- 3)- Amil R Agarwal, Christa L LiBrizzi, Lauren Wessel, Savyasachi C Thakkar, Adam S Levin. The low and disproportionate utilization of antiresorptive therapy in patients with osseous metastasis. Journal of bone oncology. 2023, 43: 100507Cited : 1Read More
- 4)- Weimin Chen, Muhammad Ayoub, Mengyun Liao, Ruizheng Shi, Mu Zhang, Feng Su, Zhiguo Huang, Yuanzhe Li, Yi Wang, Kevin K L Wong. A fusion of VGG-16 and ViT models for improving bone tumor classification in computed tomography. Journal of bone oncology. 2023, 43: 100508Cited : 3Read More
- 5)- Ling Qiu, Lei Ma, Dan Chen, Nan Zhang, Jiao Cai, Qian Zhang, Xiao Wang, Hai Yi, Hao Yao, Fang-Yi Fan. Novel_circ_003686 regulates the osteogenic differentiation of MSCs in patients with myeloma bone disease through miR-142-5p/IGF1 axis. Journal of bone oncology. 2023, 43: 100509Cited : 0Read More
- 6)- Juan Miguel Jimenez-Andrade, Martha B Ramírez-Rosas, Sun Hee Park, Renee Parker, Matthew R Eber, Rebecca Cain, Mary Newland, Fang-Chi Hsu, Carol A Kittel, Thomas J Martin, Enriqueta Muñoz-Islas, Yusuke Shiozawa, Christopher M Peters. Evaluation of pain related behaviors and disease related outcomes in an immunocompetent mouse model of prostate cancer induced bone pain. Journal of bone oncology. 2023, 43: 100510Cited : 0Read More
- 7)- Ahmad Assi, Mohamad Farhat, Maria Catherine Rita Hachem, Ziad Zalaquett, Marven Aoun, Mohammad Daher, Amer Sebaaly, Hampig-Raphaël Kourie. Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa. Journal of bone oncology. 2023, 43: 100511Cited : 3Read More
- 8)- Zi Li, Jia-Ming Tian, Yi Chu, Hong-Yi Zhu, Jun-Jie Wang, Jun Huang. Long non-coding RNA PVT1 (PVT1) affects the expression of CCND1 and promotes doxorubicin resistance in osteosarcoma cells. Journal of bone oncology. 2023, 43: 100512Cited : 2Read More
- 9)- Rongrong Ge, Gavin M Huang. Targeting transforming growth factor beta signaling in metastatic osteosarcoma. Journal of bone oncology. 2023, 43: 100513Cited : 1Read More
- 10)- Minna K Laitinen, Joachim Thorkildsen, Guy Morris, Vineet Kurisunkal, Jonathan D Stevenson, Michael C Parry, Lee M Jeys. Intraosseous conventional central chondrosarcoma does not metastasise irrespective of grade in pelvis, scapula and in long bone locations. Journal of bone oncology. 2023, 43: 100514Cited : 3Read More
- 11)- Mohamed Diaty Diarra, Zengjie Zhang, Zhan Wang, Eloy Yinwang, Hengyuan Li, Shengdong Wang, Peng Lin, Xin Huang, Zhaoming Ye. Surgical Options for Aggressive Vertebral Hemangiomas：A case series, literature review and treatment recommendations. Journal of bone oncology. 2023, 43: 100515Cited : 2Read More
